Skip to content

Saturday, November 1, 2025

Latest:

Beyond a restroom pass: ‘silent crisis’ of childhood constipation in schools
Uncovering what drives cell identity
Growing Up Baylor: Dr. Adil Ahmed
Handle with care: Avoiding hand injuries during Halloween pumpkin carving
Novel approach restores sperm production in mouse model of infertility

Home
Momentum
From The Labs
- About From the Labs
- Follow From The Labs on Twitter
Policywise
- About PolicyWise
- Follow @BCMEthics on Twitter
The Stitch
- About The Stitch
Progress Notes
bcm.edu

5D4

5D4 disrupts several molecular pathways, including MYC, that lead to cancer growth

October 26, 2023 5D4, Breast Cancer, cancer inhibitor, MYC, ovarian cancer, PARP inhibitor, Research, TopBP1

The findings strongly support the potential use of TopBP1 inhibitors as a targeted cancer therapy.

From the Labs: Image of the Month

From the Labs: Neurons in a Huntington’s brain

Healthy Habits: A DOC-umentary Series

Archives

Archives

Search

©1998 - 2023 Baylor College of Medicine®
One Baylor Plaza, Houston, Texas 77030
(713) 798-4951